NATCO Pharma Shares Tumble 19% After Q3 Profit Declines 37% YoY
Key Highlights: NATCO Pharma’s Q3 net profit dropped 37.75% YoY to ₹132.4 crore. Stock plunged 16.06% to an intraday low of ₹1,023 in early trade. Formulation exports fell sharply to ₹285.8 crore from ₹605.6 crore YoY. API revenue saw an increase to ₹66.6 crore from ₹46.3 crore YoY. Board declared …